# FTSE 100: Market Overview

- Link: https://www.directorstalkinterviews.com/ftse-100-market-overview
- Published: 2022-08-24T09:47:09+01:00
- Author: Giles

# FTSE 100: Market Overview

**Day High **

**Day Low **

**52 Week High**

**52 Week Low**

## Latest FTSE 100 News

![Imperial Brands](https://www.directorstalkinterviews.com/wp-content/uploads/2025/
05/Imperial-Brands-300x200.jpg "FTSE 100: Market Overview ()")

###  󠀁[ Imperial Brands delivers sixth consecutive year of growth ](https://www.directorstalkinterviews.com/imperial-brands-delivers-sixth-consecutive-year-of-growth/4121269921)󠁿

  17 November 2026

Imperial Brands reported 2.1% growth in tobacco and next-generation product net 
revenue to £8.5bn for FY26, marking its sixth consecutive year of growth. Adjusted
operating profit increased 3.7%, while adjusted earnings per share rose 8.8% to 
341p.

 [ Read More » ](https://www.directorstalkinterviews.com/imperial-brands-delivers-sixth-consecutive-year-of-growth/4121269921)

![Diploma Plc](https://www.directorstalkinterviews.com/wp-content/uploads/2024/11/
Diploma-Plc-300x116.webp "FTSE 100: Market Overview ()")

###  󠀁[ Diploma delivers 45% earnings growth as revenue rises 21% to £1.84bn ](https://www.directorstalkinterviews.com/diploma-delivers-45-earnings-growth-as-revenue-rises-21-to-1-84bn/4121269916)󠁿

  17 November 2026

Diploma reported a 21% increase in FY26 revenue to £1.84bn, with adjusted earnings
per share rising 45% to 255.6p. Organic revenue growth reached 15%, while adjusted
operating profit increased 42% to £487.1m.

 [ Read More » ](https://www.directorstalkinterviews.com/diploma-delivers-45-earnings-growth-as-revenue-rises-21-to-1-84bn/4121269916)

![LGEN](https://www.directorstalkinterviews.com/wp-content/uploads/2025/10/Legal__General-
300x225.jpg "FTSE 100: Market Overview ()")

###  󠀁[ Legal & General maintains growth targets as solvency ratio rises to 213% ](https://www.directorstalkinterviews.com/legal-general-maintains-growth-targets-as-solvency-ratio-rises-to-213/4121269827)󠁿

  16 November 2026

Legal & General reported continued momentum across its businesses in the third quarter,
with Workplace net flows reaching £8bn year to date and Institutional Retirement
transactions totalling £6.7bn written or exclusive. The Solvency II ratio increased
to 213%, while the Group expects 2026 core operating EPS growth to exceed the upper
end of its 6-9% target range.

 [ Read More » ](https://www.directorstalkinterviews.com/legal-general-maintains-growth-targets-as-solvency-ratio-rises-to-213/4121269827)

![Astrazeneca](https://www.directorstalkinterviews.com/wp-content/uploads/2020/10/
AstraZeneca_HQ-300x225.jpg "FTSE 100: Market Overview ()")

###  󠀁[ AstraZeneca advances three treatments across Cardiovascular, Cancer and Rare Diseases ](https://www.directorstalkinterviews.com/astrazeneca-advances-three-treatments-across-cardiovascular-cancer-and-rare-diseases/4121269825)󠁿

  16 November 2026

AstraZeneca has secured a positive EU recommendation for Baxfendy for uncontrolled
hypertension, US approval for an Imfinzi-based bladder cancer treatment and EU approval
for Klygefa for generalised myasthenia gravis, expanding its treatment portfolio
across three therapeutic areas.

 [ Read More » ](https://www.directorstalkinterviews.com/astrazeneca-advances-three-treatments-across-cardiovascular-cancer-and-rare-diseases/4121269825)

![LAND](https://www.directorstalkinterviews.com/wp-content/uploads/2026/09/Landsec-
300x200.webp "FTSE 100: Market Overview ()")

###  󠀁[ Landsec raises FY28 earnings growth outlook following £611m retail acquisitions ](https://www.directorstalkinterviews.com/landsec-raises-fy28-earnings-growth-outlook-following-611m-retail-acquisitions/4121269682)󠁿

  13 November 2026

Landsec expects improved high-single-digit EPRA EPS growth in FY28, supported by
£611m of retail acquisitions, 6.2% rental income growth and stronger portfolio performance.
The company also maintains its target of approximately 5% annual EPS growth through
to FY30.

 [ Read More » ](https://www.directorstalkinterviews.com/landsec-raises-fy28-earnings-growth-outlook-following-611m-retail-acquisitions/4121269682)

![Rentokil Initial plc](https://www.directorstalkinterviews.com/wp-content/uploads/
2025/01/Rentokil-Initial-plc-300x150.jpg "FTSE 100: Market Overview ()")

###  󠀁[ Rentokil Initial appoints Duncan Palmer as Non-Executive Director ](https://www.directorstalkinterviews.com/rentokil-initial-appoints-duncan-palmer-as-non-executive-director/4121269687)󠁿

  13 November 2026

Rentokil Initial has appointed former Cushman & Wakefield CFO Duncan Palmer as a
Non-Executive Director with immediate effect. Palmer brings extensive international
financial and corporate governance experience, having previously held senior roles
at RELX, Owens Corning and Shell.

 [ Read More » ](https://www.directorstalkinterviews.com/rentokil-initial-appoints-duncan-palmer-as-non-executive-director/4121269687)

![GSK](https://www.directorstalkinterviews.com/wp-content/uploads/2022/10/GSK-vaccine-
300x200.jpg "FTSE 100: Market Overview ()")

###  󠀁[ GSK secures positive EU recommendation for Bexsero Meningitis booster ](https://www.directorstalkinterviews.com/gsk-secures-positive-eu-recommendation-for-bexsero-meningitis-booster/4121269689)󠁿

  13 November 2026

GSK has received a positive recommendation from the EMA’s CHMP for a Bexsero label
update to include a single booster dose for people aged 10 and over previously vaccinated
against meningococcal B.

 [ Read More » ](https://www.directorstalkinterviews.com/gsk-secures-positive-eu-recommendation-for-bexsero-meningitis-booster/4121269689)

![Aviva Plc | AV](https://www.directorstalkinterviews.com/wp-content/uploads/2025/
05/Aviva-Plc.jpg "FTSE 100: Market Overview ()")

###  󠀁[ Aviva raises 2026 earnings outlook as insurance premiums grow 19% ](https://www.directorstalkinterviews.com/aviva-raises-2026-earnings-outlook-as-insurance-premiums-grow-19/4121269684)󠁿

  13 November 2026

Aviva reported 19% growth in General Insurance premiums to £11.8bn and a 31% increase
in Wealth net flows to £10.9bn in the first nine months of 2026. Assets under management
reached £267bn, while the insurer improved its combined operating ratio to 93.8%.
Aviva remains on track to deliver its 11% operating EPS growth target for 2026.

 [ Read More » ](https://www.directorstalkinterviews.com/aviva-raises-2026-earnings-outlook-as-insurance-premiums-grow-19/4121269684)

![Rolls Royce Holdings plc](https://www.directorstalkinterviews.com/wp-content/uploads/
2023/11/Rolls-Royce-300x178.jpg "FTSE 100: Market Overview ()")

###  󠀁[ Rolls-Royce accelerates £1.5bn share buyback, profits and cash flow remain on track ](https://www.directorstalkinterviews.com/rolls-royce-accelerates-1-5bn-share-buyback-profits-and-cash-flow-remain-on-track/4121269562)󠁿

  12 November 2026

Rolls-Royce has brought forward a £1.5bn share buyback as strong operational and
financial progress supports its 2026 outlook. The Group continues to target underlying
operating profit of £4.7bn to £4.9bn and free cash flow of £3.8bn to £4.0bn.

 [ Read More » ](https://www.directorstalkinterviews.com/rolls-royce-accelerates-1-5bn-share-buyback-profits-and-cash-flow-remain-on-track/4121269562)

 « Previous [Next »](https://www.directorstalkinterviews.com/ftse-100-market-overview/2)

**The FTSE 100**, also known as the Financial Times Stock Exchange 100 Index or 
FTSE 100 Index is a share index of the 100 companies listed on the UK [London Stock Exchange](https://www.londonstockexchange.com/https://www.londonstockexchange.com/)
with the highest market capitalisation. It is seen as a gauge of prosperity for 
businesses regulated by [UK company law](http://www.legislation.gov.uk/ukpga/2006/46/pdfs/ukpga_20060046_en.pdf).

 
